Dendrimers in Anticancer Drug Delivery: Mechanism of Interaction of Drug and Dendrimers
Overview
Biotechnology
Affiliations
Dendrimers represents a novel class of macromolecules, which are derived from branches upon branches type structural design. Dendrimers are emerging as promising drug-delivery molecule because of their extraordinary properties including membrane interaction, monodispersity, well-defined size, shape and molecular weight, etc. Drugs interact with dendrimers in three ways; (a) physical encapsulation, (b) electrostatic interactions, and (c) covalent conjugations. Due to compact, globular structure and availability of interior cavity spaces and multiple surface functional groups, drug molecules can be encapsulated both in the interior of the dendrimers (physical encapsulation) as well as attached to the surface functional groups (covalent conjugations).
Nanoparticles as a novel key driver for the isolation and detection of circulating tumour cells.
Bashir S, Zia M, Shoukat M, Kaleem I, Bashir S Sci Rep. 2024; 14(1):22580.
PMID: 39343959 PMC: 11439955. DOI: 10.1038/s41598-024-67221-4.
Dendrimers: Advancements and Potential Applications in Cancer Diagnosis and Treatment-An Overview.
Crintea A, Motofelea A, Sovrea A, Constantin A, Crivii C, Carpa R Pharmaceutics. 2023; 15(5).
PMID: 37242648 PMC: 10221618. DOI: 10.3390/pharmaceutics15051406.
Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers.
Kumar G, Virmani T, Sharma A, Pathak K Pharmaceutics. 2023; 15(3).
PMID: 36986748 PMC: 10055866. DOI: 10.3390/pharmaceutics15030889.
A Glimpse into Dendrimers Integration in Cancer Imaging and Theranostics.
Cruz A, Barbosa J, Antunes P, Bonifacio V, Pinto S Int J Mol Sci. 2023; 24(6).
PMID: 36982503 PMC: 10049703. DOI: 10.3390/ijms24065430.
Advances in Lung Cancer Treatment Using Nanomedicines.
Sharma A, Shambhwani D, Pandey S, Singh J, Lalhlenmawia H, Kumarasamy M ACS Omega. 2023; 8(1):10-41.
PMID: 36643475 PMC: 9835549. DOI: 10.1021/acsomega.2c04078.